As expected, tumors were more likely to present with PD-L1+ TILs, Tim-3+ TILs and LAG-3+ TILs in a CD8-rich environment rather than a CD4-rich environment, indicating an adaptive immune status in ESCC. The gene discussed is LAG3; the disease is esophageal squamous cell carcinoma.